Ladenburg Thalmann Reiterates Buy on Rhythm Pharmaceuticals, Maintains $35 Price Target
Ladenburg Thalmann analyst Michael Higgins reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $35 price target.
Needham Reiterates Buy on CompoSecure, Maintains $15 Price Target
Needham analyst John Todaro reiterates CompoSecure (NASDAQ:CMPO) with a Buy and maintains $15 price target.
HC Wainwright & Co. Reiterates Buy on MiMedx Group, Maintains $8 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target.
HC Wainwright & Co. Reiterates Buy on G1 Therapeutics, Maintains $11 Price Target
HC Wainwright & Co. analyst Edward White reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $11 price target.
HC Wainwright & Co. Reiterates Buy on IVERIC bio, Maintains $35 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target.
Needham Reiterates Buy on Microchip Technology, Maintains $110 Price Target
Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target.
Tigress Financial Reiterates Buy on Snap-on, Raises Price Target to $302
Tigress Financial analyst Ivan Feinseth reiterates Snap-on (NYSE:SNA) with a Buy and raises the price target from $298 to $302.
Telsey Advisory Group Reiterates Outperform on Clear Secure, Maintains $38 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Clear Secure (NYSE:YOU) with a Outperform and maintains $38 price target.
Telsey Advisory Group Reiterates Outperform on Dollar Tree, Maintains $165 Price Target
Telsey Advisory Group analyst Joseph Feldman reiterates Dollar Tree (NASDAQ:DLTR) with a Outperform and maintains $165 price target.
Needham Reiterates Buy on Rhythm Pharmaceuticals, Maintains $32 Price Target
Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $32 price target.